The sales of beta blocking medicines in Italy have shown a projected growth from 2024 to 2028. In 2023, the actual value of sales stood at a certain point, which is not specified here. The forecast predicts a progressive increase in US Dollars PPP Per Capita from 2024 to 2028, indicating a steady demand.
Year-on-year analysis:
- From 2024 to 2025, there is a slight increase of 3.67%.
- 2025 to 2026 experiences a growth of 3.54%.
- The period from 2026 to 2027 shows a 2.56% rise.
- A further increase of 3.33% is expected from 2027 to 2028.
The Compound Annual Growth Rate (CAGR) over these five years reflects an average annual growth rate, providing a clear indication of ongoing expansion within the sector.
Future trends to watch include advancements in medical technology and a potential boost in demand driven by increased awareness and diagnostic rates of cardiovascular diseases, alongside policy changes in healthcare funding.
